EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Common Biological Properties of Mycobacterium tuberculosis MmpL3 Inhibitors

Lauren Ames, Renee Allen, Helena I M Boshoff iD, Laura A T Cleghorn iD, Curtis A Engelhart, Dirk Schnappinger iD, Tanya Parish iD

ACS Infectious Diseases · 12.09.2025 · 11 (9) · 2523-2533

DOI: 10.1021/acsinfecdis.5c00394 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Infectious Diseases, online erschienen am 19.08.2025. Verfasst von Lauren Ames und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Global Infectious Disease, Seattle Children's Research Institute, 1900 Ninth Ave, Seattle, Washington 98101, United States. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Antitubercular Agents, Bacterial Proteins. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Gates Foundation, Division of Intramural Research, Foundation for the National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisAntitubercular AgentsBacterial ProteinsMicrobial Sensitivity TestsReactive Oxygen SpeciesCell WallAdenosine TriphosphateAnimalsHumansMutationMiceTuberculosisMembrane Transport Proteins

Stichwörter der Autor:innen

MmpL3Mycobacterium tuberculosiscell wallmutationstuberculosis

Substanzen

Antitubercular AgentsBacterial ProteinsMmpL3 protein, Mycobacterium tuberculosisReactive Oxygen SpeciesAdenosine TriphosphateMembrane Transport Proteins

Autor:innen und Institutionen

  • Center for Global Infectious Disease, Seattle Children's Research Institute, 1900 Ninth Ave, Seattle, Washington 98101, United States.
  • Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland 20892, United Sta…
  • Drug Discovery Unit, Wellcome Centre for Anti-infectives Research, University of Dundee, Dundee DD1 5EH, United Kingdom.
  • Weill Cornell Medicine Graduate School of Medical Sciences, 1300 York Ave, New York, NY 10065, United States.
  • Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington 98195, United States.

ORCID-Profile: Helena I M Boshoff, Laura A T Cleghorn, Dirk Schnappinger, Tanya Parish

Förderung

  • Gates Foundation
  • Division of Intramural Research
  • Foundation for the National Institutes of Health
  • Bill and Melinda Gates Foundation

Zitieren

APA

Ames, L., Allen, R., Boshoff, H. I. M., Cleghorn, L. A. T., Engelhart, C. A., Schnappinger, D., & Parish, T. (2025). Common Biological Properties of Mycobacterium tuberculosis MmpL3 Inhibitors. ACS Infectious Diseases, 11(9), 2523-2533. https://doi.org/10.1021/acsinfecdis.5c00394

Vancouver

Ames L, Allen R, Boshoff HIM, Cleghorn LAT, Engelhart CA, Schnappinger D, et al. Common Biological Properties of Mycobacterium tuberculosis MmpL3 Inhibitors. ACS Infectious Diseases. 2025;11(9):2523-2533. doi:10.1021/acsinfecdis.5c00394

BibTeX
@article{Ames2025,
  author = {Ames, Lauren and Allen, Renee and Boshoff, Helena I M and Cleghorn, Laura A T and Engelhart, Curtis A and Schnappinger, Dirk and Parish, Tanya},
  title = {Common Biological Properties of Mycobacterium tuberculosis MmpL3 Inhibitors},
  journal = {ACS Infectious Diseases},
  year = {2025},
  volume = {11},
  number = {9},
  pages = {2523--2533},
  doi = {10.1021/acsinfecdis.5c00394}
}
Kostenlos starten →